Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906), a Peripherally Selective D 2/D 3 Dopamine Receptor Antagonist, in the Presence and Absence of Itraconazole, a Potent CYP 3A4 Inhibitor
www.dovepress.com